{
    "2019-11-14": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Livongo Bounces Back After Revenue Guidance Boost",
                "features": {
                    "keywords": [
                        "Livongo",
                        "bounces back",
                        "revenue guidance",
                        "boost"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes",
                "features": {
                    "keywords": [
                        "FDA",
                        "panel votes",
                        "Lilly",
                        "Jardiance",
                        "Type I Diabetes"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Celldex (CLDX) Q3 Loss Narrower Than Expected, Revenues Miss",
                "features": {
                    "keywords": [
                        "Celldex",
                        "Q3 loss",
                        "narrower",
                        "expected",
                        "revenues miss"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}